Evidence map›Paper›PMID 33763056›Full record

ArticleFrontiers in immunology2020

Proteinase-Mediated Macrophage Signaling in Psoriatic Arthritis.

Fatima Abji, Mozhgan Rasti, Alejandro Gómez-Aristizábal, Carla Muytjens, Mahmoud Saifeddine, Koichiro Mihara, Majid Motahhari, Rajiv Gandhi, Sowmya Viswanathan, Morley D Hollenberg and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Fatima AbjiSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Mozhgan RastiSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Alejandro Gómez-AristizábalSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Carla MuytjensSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Mahmoud SaifeddineDepartment of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Koichiro MiharaDepartment of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Majid MotahhariDepartment of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Rajiv GandhiSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Sowmya ViswanathanSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Morley D HollenbergDepartment of Physiology & Pharmacology, University of Calgary Cumming School of Medicine, Calgary, AB, Canada.
Katerina OikonomopoulouSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
Vinod ChandranSchroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.
University Health Network · CAUniversity of Calgary · CAKrembil Research InstituteToronto Western Hospital · CAUniversity of Toronto · CA

Funding

CIHR PJT 148565
6 · The paper itself

Abstract

Objective: Multiple proteinases are present in the synovial fluid (SF) of an arthritic joint. We aimed to identify inflammatory cell populations present in psoriatic arthritis (PsA) SF compared to osteoarthritis (OA) and rheumatoid arthritis (RA), identify their proteinase-activated receptor 2 (PAR2) signaling function and characterize potentially active SF serine proteinases that may be PAR2 activators. Methods: Flow cytometry was used to characterize SF cells from PsA, RA, OA patients; PsA SF cells were further characterized by single cell 3'-RNA-sequencing. Active serine proteinases were identified through cleavage of fluorogenic trypsin- and chymotrypsin-like substrates, activity-based probe analysis and proteomics. Fluo-4 AM was used to monitor intracellular calcium cell signaling. Cytokine expression was evaluated using a multiplex Luminex panel. Results: PsA SF cells were dominated by monocytes/macrophages, which consisted of three populations representing classical, non-classical and intermediate cells. The classical monocytes/macrophages were reduced in PsA compared to OA/RA, whilst the intermediate population was increased. PAR2 was elevated in OA vs. PsA/RA SF monocytes/macrophages, particularly in the intermediate population. PAR2 expression and signaling in primary PsA monocytes/macrophages significantly impacted the production of monocyte chemoattractant protein-1 (MCP-1). Trypsin-like serine proteinase activity was elevated in PsA and RA SF compared to OA, while chymotrypsin-like activity was elevated in RA compared to PsA. Tryptase-6 was identified as an active serine proteinase in SF that could trigger calcium signaling partially Conclusion: PAR2 and its activating proteinases, including tryptase-6, can be important mediators of inflammation in PsA. Components within this proteinase-receptor axis may represent novel therapeutic targets.

Indexed as

Arthritis, PsoriaticCalcium SignalingFemaleHumansMacrophagesMaleReceptor, PAR-2TryptasesF2RL1 protein, humanReceptor, PAR-2TryptasesmacrophagemonocytePAR2serine proteinasespondyloarthritissynovial fluidtryptase-6

Identifiers

PMID33763056
PMCPMC7982406
OpenAlexW3135725811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.